Drug offers hope on tackling cancer

A dual-action drug offering hope to people with therapy-resistant cancer tumours could be available within five years.

The Royal College of Surgeons in Ireland and Almac Discovery, a biopharmaceutical company, are working together to explore the potential of the drug.

The research is a critical step on the journey to making the drug available to patients for whom all other forms of therapy have failed.